Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1995 3
1998 3
2000 1
2003 2
2004 1
2005 4
2006 3
2007 4
2008 4
2009 5
2010 7
2011 7
2012 8
2013 13
2014 9
2015 5
2016 13
2017 12
2018 10
2019 4
2020 10
2021 11
2022 11
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Mercury Reduction by Nanoparticulate Vivianite.
Etique M, Bouchet S, Byrne JM, ThomasArrigo LK, Kaegi R, Kretzschmar R. Etique M, et al. Among authors: bouchet s. Environ Sci Technol. 2021 Mar 2;55(5):3399-3407. doi: 10.1021/acs.est.0c05203. Epub 2021 Feb 8. Environ Sci Technol. 2021. PMID: 33554594 Free PMC article.
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G. Benaboud S, et al. Among authors: bouchet s. J Antimicrob Chemother. 2023 Mar 2;78(3):853-854. doi: 10.1093/jac/dkad009. J Antimicrob Chemother. 2023. PMID: 36683308 No abstract available.
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C; ANRS-AC43 Clinical Pharmacology Committee, SFPT Therapeutic Drug Monitoring and Treatment Personalization group. Venisse N, et al. Among authors: bouchet s. Antiviral Res. 2020 Sep;181:104866. doi: 10.1016/j.antiviral.2020.104866. Epub 2020 Jul 10. Antiviral Res. 2020. PMID: 32659293 Free PMC article. Review.
Worldwide phylogeography and history of wheat genetic diversity.
Balfourier F, Bouchet S, Robert S, De Oliveira R, Rimbert H, Kitt J, Choulet F; International Wheat Genome Sequencing Consortium; BreedWheat Consortium; Paux E. Balfourier F, et al. Among authors: bouchet s. Sci Adv. 2019 May 29;5(5):eaav0536. doi: 10.1126/sciadv.aav0536. eCollection 2019 May. Sci Adv. 2019. PMID: 31149630 Free PMC article.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Among authors: bouchet s. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
144 results